Advertisement
Covid-19 Series| Volume 154, P212-215, February 2023

The Global Evidence Commission's report provided a wake-up call for the evidence community

  • Ruth Stewart
    Correspondence
    Corresponding author. Africa Centre for Evidence, University of Johannesburg, Research Village, Bunting Road Campus, Auckland Park, Johannesburg, South Africa; Social Science Research Unit, University College London Institute of Education, London, UK. Tel.: +27 (0)72 713 7297.
    Affiliations
    Africa Centre for Evidence, University of Johannesburg, House 2, Research Village, Bunting Road Campus, 2006 Johannesburg, South Africa
    Search for articles by this author
  • Isabelle Boutron
    Affiliations
    Université de Paris, INSERM, INRAE, CNAM, Centre of Research in Epidemiology and Statistics (CRESS), F-75004 Paris, France

    Centre d’Épidémiologie Clinique, AP-HP, Hôpital Hôtel-Dieu, F-75004 Paris, France

    Cochrane France, F-75004 Paris, France
    Search for articles by this author
  • Elie A. Akl
    Affiliations
    Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

    Department of Health Research Methods, Evidence, and Impact (HEI) at McMaster University, Hamilton, Ontario, Canada
    Search for articles by this author
      The Global Commission on Evidence to Address Societal Challenges was convened to propose recommendations to favor the use of evidence to overcome societal challenges similar to the COVID-19 pandemic.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Epidemiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Boutron I.
        • Chaimani A.
        • Meerpohl J.J.
        • Hróbjartsson A.
        • Devane D.
        • Rada G.
        • et al.
        • COVID-NMA Consortium
        The COVID-NMA project: building an evidence ecosystem for the COVID-19 pandemic.
        Ann Intern Med. 2020; 173: 1015-1017
        • Global Commission on Evidence to Address Societal Challenges
        The evidence commission report: a wake-up call and path forward for decision- makers, evidence intermediaries, and impact-oriented evidence producers.
        McMaster Health Forum, Hamilton2022 (ISBN 978-1-927565-31-5)
        • Gough D.
        • Davies P.
        • Jamtvedt G.
        • Langlois E.
        • Littell J.
        • Lotfi T.
        • et al.
        Evidence synthesis international (ESI): position statement.
        Syst Rev. 2020; 9: 155
        • Ravaud P.
        • Créquit P.
        • Williams H.C.
        • Meerpohl J.
        • Craig J.C.
        • Boutron I.
        Future of evidence ecosystem series: 3. From an evidence synthesis ecosystem to an evidence ecosystem.
        J Clin Epidemiol. 2020; 123: 153-161
        • Kochhar S.
        • Knoppers B.
        • Gamble C.
        • Chant A.
        • Koplan J.
        • Humphreys G.S.
        Clinical trial data sharing: here’s the challenge.
        BMJ Open. 2019; 9: e032334
        • Stewart R.
        • El-Harakeh A.
        • Cherian S.A.
        • LMIC members of COVID-END
        Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.
        Lancet. 2020; 396: 1539-1541
        • Boutron I.
        • Créquit P.
        • Williams H.
        • Meerpohl J.
        • Craig J.C.
        • Ravaud P.
        Future of evidence ecosystem series: 1. Introduction Evidence synthesis ecosystem needs dramatic change.
        J Clin Epidemiol. 2020; 123: 135-142